PetCanClarity^® is a pan-cancer pan-indication treatment response monitoring test for dogs, which is based on 4ml of peripheral blood and mapping the panoramic cancer genome by shallow whole-genome sequencing (sWGS) data. It evaluates the copy number aberration (CNA) and fragment size (FS) to calculate molecular tumor burden (MTB) and to access the therapeutic efficacy for the late-stage cancer dogs in the course of treatment.

Scope of application: A pet with terminal cancer

Test indicators: Tumor load index

Sample requirements: 4ml of peripheral whole blood (non coagulation and hemolysis required)

Detection cycle: 10 working days

Detection significance: By establishing the baseline before treatment and the real-time dynamic curve of molecular efficacy index in the treatment process of pets with advanced cancer, the individualized treatment management of pets is realized, which provides important clinical reference information for whether to continue the current treatment plan and formulate the next treatment plan in time

Recommended sampling time:

Recommended sampling time: the day before the start of the second treatment cycle;

The day before the start of every two treatment cycles